HOXC13 and posterior cortical atrophy: Further classifying PCa patients into five categories (stage I to stage V) based on pathological grade, we found that HOXC13 was highly expressed in patients with high stage, and interestingly, HOXC13 was most highly expressed in patients with stage IV (Fig. 4C and D).